tiprankstipranks
Abivax SA (DE:2X1)
FRANKFURT:2X1
Holding DE:2X1?
Track your performance easily

Abivax SA (2X1) Financial Statements

2 Followers

Abivax SA Financial Overview

Abivax SA's market cap is currently ―. The company's EPS TTM is €-3.281; its P/E ratio is -2.21; Abivax SA is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is €-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 650.00M--$ 688.00M$ 438.00M
Gross Profit$ 650.00M--$ 688.00M$ 312.00M
EBIT$ 179.00M----
EBITDA$ 488.00M----
Net Income Common Stockholders$ 168.00M--$ -77.00M$ 460.00M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 648.00M$ 632.00M$ 251.94M$ 244.00M$ 127.00M
Total Assets$ 6.85B$ 7.08B$ 327.06M$ 6.89B$ 7.02B
Total Debt$ 2.63B$ 2.63B$ 55.47M$ 2.83B$ 2.85B
Net Debt$ 1.98B$ 1.99B$ -196.48M$ 2.59B$ 2.72B
Total Liabilities$ 4.40B$ 4.51B$ 131.05M$ 4.53B$ 4.56B
Stockholders Equity$ 2.39B$ 2.51B$ 196.01M$ 2.28B$ 2.35B
Cash Flow-
Free Cash Flow$ 246.00M$ -399.00M-$ 141.00M$ -340.00M
Operating Cash Flow$ 246.00M$ -399.00M-$ 181.00M$ -283.00M
Investing Cash Flow$ 1.23B$ -240.00M-$ -70.00M$ -77.00M
Financing Cash Flow$ -1.24B$ -364.00M-$ -62.00M$ -511.00M
Currency in USD

Abivax SA Earnings and Revenue History

Abivax SA Debt to Assets

Abivax SA Cash Flow

Abivax SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis